Exploring the interplay of selenoproteins and mir-675 in breast cancer: a focus on radiotherapy effects


Degirmencioglu S., Öğüt S., BAHTİYAR N., Aydemir B., Karaçetin D., Cinemre F. B., ...More

International Journal of Radiation Biology, vol.101, no.6, pp.572-580, 2025 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 101 Issue: 6
  • Publication Date: 2025
  • Doi Number: 10.1080/09553002.2025.2473962
  • Journal Name: International Journal of Radiation Biology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.572-580
  • Keywords: Breast cancer, mir-675, radiotherapy, selenoproteins
  • Istanbul University Affiliated: Yes

Abstract

Objectives: The present study aims to investigate the changes in the expression levels of miR-675 and some selenoproteins (Sel K, Sel W, and Sel P) in patients with breast cancer, before and after radiotherapy. Subjects and methods: This study included 35 breast cancer patients who applied to the Department of Radiation Oncology for radiotherapy and 25 healthy female controls. miR-675 expressions were analyzed by using quantitative reverse-transcription polymerase chain reaction (qRT-PCR). Western blot was conducted to determine Sel K, Sel W, and Sel P expression levels. Biochemical parameters and complete blood count were analyzed by autoanalyzer system and automatic cell counter, respectively. Results: Plasma Sel K protein expression levels were decreased in the after-radiotherapy group compared to the control and before-radiotherapy groups, but plasma miR-675 expression levels were lower in both before and after radiotherapy groups compared to the control group. Conclusion: Our findings showed that miR-675 and Sel K expression levels changed after radiotherapy in breast cancer patients. These changes may have the potential to be biomarkers for the effectiveness of radiotherapy in breast cancer.